2024
|
Invention
|
Sabizabulin for use in the treatment of polycystic kidney disease. The present invention relates ... |
|
Invention
|
Sulindac and/or sulindac sulfide for the treatment of angelman syndrome. The present invention re... |
2023
|
Invention
|
Nitroxoline for use in the treatment or prevention of a malignant peripheral nerve sheath tumour.... |
|
Invention
|
Polymorph of the ketoglutarate or p-toleunesulphonate salt of mebendazole. The present invention ... |
|
Invention
|
Ibudilast and gaboxadol for the treatment of fragile x syndrome. tt thereof; and • (ii) ibudilast... |
2022
|
Invention
|
Nitroxoline for use in the treatment or prevention of a plexiform neurofibroma. The present inven... |
|
Invention
|
Kit, composition, and combination therapy for fragile x syndrome.
Described herein are kits, com... |
|
Invention
|
Nitroxoline for use in the treatment of cutaneous neurofibroma.
The present invention relates to... |
|
Invention
|
Nitroxoline for use in the treatment of cutaneous neurofibroma. The present invention relates to ... |
|
Invention
|
Lovastatin for use in the treatment of neuroblastoma. The present invention relates to compositio... |
|
Invention
|
Prochlorperazine for use in the treatment of neuroblastoma. The present invention relates to comp... |
|
Invention
|
Trifluoperazine for use in the treatment of neurobéastoma. The present invention relates to compo... |
2021
|
Invention
|
Mebendazole for use in the treatment of autosomal dominant polycystic kidney disease or autosomal... |
|
Invention
|
Composition for treatment of fragile x syndrome. The present invention relates to compositions an... |
2020
|
Invention
|
Treatment of fragile x syndrome with ibudilast in combination with metformin, cannbidiol, sertral... |
|
Invention
|
Treatment of fragile x syndrome.
The present invention relates to a composition comprising ibudi... |
|
Invention
|
Treatment of fragile x syndrome. The present invention relates to a composition comprising ibudil... |
|
Invention
|
Treatment of pitt-hopkins syndrome. The present invention relates to compositions and kits compri... |
|
Invention
|
Minocycline for the treatment of pitt-hopkins syndrome.
The present invention relates to minocyc... |
|
Invention
|
Treatment of pitt-hopkins syndrome.
The present invention relates to amitriptyline or a pharmace... |
|
Invention
|
Treatment of pitt-hopkins syndrome. The present invention relates to amitriptyline or a pharmaceu... |
|
Invention
|
Prochlorperazine for the treatment of pitt-hopkins syndrome. The present invention relates to pro... |
|
Invention
|
Minocycline for the treatment of pitt-hopkins syndrome. The present invention relates to minocycl... |
|
P/S
|
Pharmaceutical drugs; drugs for medical purposes; medicines for human purposes; all of the goods ... |
|
P/S
|
Pharmaceutical drugs; drugs for medical purposes; medicines
for human purposes. Scientific and t... |
|
P/S
|
Scientific and technological services and research and
design relating thereto; industrial analy... |
2019
|
Invention
|
Tricyclic dibenzothiazepine type compounds for use in the therapy of cdkl5 disorder.
Tricyclic d... |
|
Invention
|
Treatment of fragile x syndrome. Described herein is the use of sulindac in the treatment of frag... |
|
Invention
|
Treatment of fragile x syndrome. The present invention relates to sulindac, or a pharmaceutically... |
|
Invention
|
Kit, composition, and combination therapy for fragile x syndrome. Described herein are kits, comp... |
|
Invention
|
Kit, composition and combination therapy for fragile x syndrome. The present invention relates to... |
2016
|
Invention
|
Biomarker signatures predictive of drug response. A method of prognosing the response of a patien... |
|
Invention
|
Tricyclic dibenzothiazepine type compounds for use in the therapy of cdkl5 disorder. Tricyclic di... |